BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17580062)

  • 21. [Osteogenesis imperfecta].
    Forin V
    Presse Med; 2007 Dec; 36(12 Pt 2):1787-93. PubMed ID: 17560761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing in bisphosphonate-treated children with osteogenesis imperfecta: our experience in thirty six young patients.
    Ting TH; Zacharin MR
    Clin Otolaryngol; 2012 Jun; 37(3):229-33. PubMed ID: 22708940
    [No Abstract]   [Full Text] [Related]  

  • 23. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE
    Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
    [No Abstract]   [Full Text] [Related]  

  • 24. Advances in the Classification and Treatment of Osteogenesis Imperfecta.
    Thomas IH; DiMeglio LA
    Curr Osteoporos Rep; 2016 Feb; 14(1):1-9. PubMed ID: 26861807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteogenesis imperfecta.
    Bhadada SK; Santosh R; Bhansali A; Upreti V; Dutta P
    J Assoc Physicians India; 2009 Jan; 57():33-6. PubMed ID: 19753756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception.
    Chen CP; Lin SP; Su YN; Huang JP; Chern SR; Su JW; Wang W
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):305-7. PubMed ID: 22795118
    [No Abstract]   [Full Text] [Related]  

  • 28. Dental management of patients at risk of osteochemonecrosis of the jaws: a critical review.
    Fedele S; Kumar N; Davies R; Fiske J; Greening S; Porter S
    Oral Dis; 2009 Nov; 15(8):527-37. PubMed ID: 19619192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
    Rogers S; Rahman N; Ryan D; Flint S; Healy C; Stassen LF
    J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145
    [No Abstract]   [Full Text] [Related]  

  • 31. Specialists play down risk of jaw condition.
    Stassen LF
    J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing dentures.
    Kyrgidis A; Teleioudis Z; Vahtsevanos K
    Int J Dent Hyg; 2010 May; 8(2):154. PubMed ID: 20522142
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteogenesis imperfecta: otologic and maxillofacial aspects.
    Bergstrom L
    Laryngoscope; 1977 Sep; 87(9 Pt 2 Suppl 6):1-42. PubMed ID: 330992
    [No Abstract]   [Full Text] [Related]  

  • 34. Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case.
    Milano M; Wright T; Loechner KJ
    Pediatr Dent; 2011; 33(4):349-52. PubMed ID: 21903004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants.
    Garg AK
    Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN; Dojcinovic I; Richter M; Hugentobler M
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS; Glorieux FH; Rauch F
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug induced osteonecrosis of the jaws.
    Weeda LW
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.